Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Schembl15061349
Molecular Weight | 472.9 g/mol |
---|---|
Molecular Formula | C23H32Cl3N3O |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 4 |
Rotatable Bond Count | 9 |
Exact Mass | 471.161096 g/mol |
Monoisotopic Mass | 471.161096 g/mol |
Topological Polar Surface Area | 43.2 Ų |
Heavy Atom Count | 30 |
Formal Charge | 0 |
Complexity | 461 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 1 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 3 |
Market Place
ABOUT THIS PAGE
35
PharmaCompass offers a list of Quinacrine API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Quinacrine manufacturer or Quinacrine supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Quinacrine manufacturer or Quinacrine supplier.
PharmaCompass also assists you with knowing the Quinacrine API Price utilized in the formulation of products. Quinacrine API Price is not always fixed or binding as the Quinacrine Price is obtained through a variety of data sources. The Quinacrine Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A QUINACRINE HCL manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of QUINACRINE HCL, including repackagers and relabelers. The FDA regulates QUINACRINE HCL manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. QUINACRINE HCL API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A QUINACRINE HCL supplier is an individual or a company that provides QUINACRINE HCL active pharmaceutical ingredient (API) or QUINACRINE HCL finished formulations upon request. The QUINACRINE HCL suppliers may include QUINACRINE HCL API manufacturers, exporters, distributors and traders.
click here to find a list of QUINACRINE HCL suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A QUINACRINE HCL DMF (Drug Master File) is a document detailing the whole manufacturing process of QUINACRINE HCL active pharmaceutical ingredient (API) in detail. Different forms of QUINACRINE HCL DMFs exist exist since differing nations have different regulations, such as QUINACRINE HCL USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A QUINACRINE HCL DMF submitted to regulatory agencies in the US is known as a USDMF. QUINACRINE HCL USDMF includes data on QUINACRINE HCL's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The QUINACRINE HCL USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of QUINACRINE HCL suppliers with USDMF on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing QUINACRINE HCL as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for QUINACRINE HCL API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture QUINACRINE HCL as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain QUINACRINE HCL and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a QUINACRINE HCL NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of QUINACRINE HCL suppliers with NDC on PharmaCompass.
QUINACRINE HCL Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of QUINACRINE HCL GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right QUINACRINE HCL GMP manufacturer or QUINACRINE HCL GMP API supplier for your needs.
A QUINACRINE HCL CoA (Certificate of Analysis) is a formal document that attests to QUINACRINE HCL's compliance with QUINACRINE HCL specifications and serves as a tool for batch-level quality control.
QUINACRINE HCL CoA mostly includes findings from lab analyses of a specific batch. For each QUINACRINE HCL CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
QUINACRINE HCL may be tested according to a variety of international standards, such as European Pharmacopoeia (QUINACRINE HCL EP), QUINACRINE HCL JP (Japanese Pharmacopeia) and the US Pharmacopoeia (QUINACRINE HCL USP).